Barclays lowered its price target for Keurig Dr Pepper on July 17, 2025, based on new insights.
1 report, 1 independent
Updated Jul 17
AI-generated analysis. Brind wrote this summary from the reports listed below. It can be wrong. Each section says how much you can rely on it, and the sources are linked so you can check.
What happened
Barclays lowered its price target for Keurig Dr Pepper on July 17, 2025, based on new insights.
Who's involved
What this event is mainly aboutKeep exploring
The entities involved
-
Barclays
British bank
- QinetiQ carried out share purchases and arranged for a share buyback execution on the London Stock Exchange.
- Financial institutions provided ratings on multiple companies on July 8, 2026, including Goldman Sachs reiterating Tesla as neutral, Barclays initiating Toast as overweight, and Bank of America rating Nvidia as a buy.
-
Keurig Dr Pepper
American beverage company
Related events
- Barclays raised its price target on Latham Group on September 1, 2026.
- Barclays boosted its price target on Bunge on August 16, 2026.
- Barclays maintained Overweight rating and raised price target on August 29, 2025.
- Barclays issued rating and price objective reports for Ubiquiti on August 1, 2026.
- Morgan Stanley reaffirmed an overweight rating on AbbVie, and Barclays raised its price objective on September 10, 2026.
Coverage
Newest first; wire copies grouped- Insider MonkeyBarclays Trims Keurig Dr Pepper (KDP) Price Target, Maintains Overweight Rating Keurig Dr Pepper Inc. (NASDAQ:KDP) is one of the Best Non-Mega Cap NASDAQ Stocks to Buy Right Now. Barclays has lowered